Ontario will resume shouldering the sex change surgery of residents after it was ordered by the province's Human Rights Commission to compensate three men whose sex change process were halted in the middle.

Since 1971, the Ontario Health Insurance Plan covered sex reassignment procedures, but in 1998 the Progressive Conservative government excluded sex change surgeries from medical procedures to be funded by the OHIP

The U.S. Food and Drug Administration (FDA) on Tuesday has reportedly approved the first birth-control pill that is designed to let women suppress their menstrual cycle indefinitely.

Lybrel, a drug from Madison, New Jersey-based company Wyeth has become the first pill that can be taken daily to halt women's periods indefinitely and prevent pregnancies. It is also the fourth new oral contraceptive that does not follow the standard schedule of 21 daily active pills, followed by seven sugar pills, a formula used to imitate a woman's monthly cycle

The U.S. Food and Drug Administration (FDA) is soon expected to give its approval for the first birth control pill that is designed to let women suppress their menstrual cycle indefinitely.

Lybrel, a drug from Madison, New Jersey-based company Wyeth would be the first pill to be taken continuously and the fourth new oral contraceptive that does not follow the standard schedule of 21 daily active pills, followed by seven sugar pills, a formula used to imitate a woman's monthly cycle

Scientists are suggesting that a contraceptive pill that promises to end the pain and misery of menstruation for millions of women has been proved safe and effective. The study, published in the December issue of Contraception, has for the first time demonstrated the safety and effectiveness of continuous-use oral contraceptives that can eliminate menstrual cycles.

Lead investigator David F. Archer, M.D., professor of obstetrics and gynecology at Eastern Virginia Medical School, said that the medicine, called Lybrel, was taken every day for a year and halted periods in more than half of the 2,000 women who used it

New research shows that babies conceived due to the failure of the "morning after" pill, levonorgestrel, are just as healthy as other babies.

The study involved 36 pregnant women who were exposed to levonorgestrel and 80 similar women who were not. A total of 25 deliveries took place in the exposed group and 69 occurred in the nonexposed group